Report cover image

Rosacea Treatment Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Publisher Global Market Insights
Published Dec 09, 2024
Length 135 Pages
SKU # GMI19463503

Description

Rosacea Treatment Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032


Rosacea treatment market size is poised to witness a 6.5% CAGR between 2024 and 2032 driven by the rising prevalence of rosacea. As awareness of rosacea increases, more individuals are seeking diagnoses and treatments, boosting the demand for effective therapies. Dermatological research advancements have made way for innovative treatments, spanning topical and oral medications, laser therapies, and advanced skincare products, all targeting diverse symptoms of rosacea.

Heightened research into the causes and triggers of rosacea has also birthed tailored treatments, that cater to individual patient needs. The surge in over-the-counter treatments, alongside new non-prescription products, addresses mild to moderate rosacea cases, broadening the market beyond traditional prescription therapies.

The overall industry is divided into type, treatment type, drug class, distribution channel, and region.

Based on type, the rosacea treatment market size from the ocular rosacea segment is anticipated to witness unprecedented growth through 2032 driven by the heightened awareness of its impact on eye health and the demand for specialized treatments. The discomfort of ocular rosacea also necessitates targeted therapies. This awareness has intensified the focus on developing treatments for eye-related rosacea symptoms.

With respect to distribution channel, the rosacea treatment market from the online pharmacies segment is predicted to record notable gains up to 2032. This is owing to the increased convenience and accessibility these settings offer for purchasing medications and skincare products. Online pharmacies also provide patients with a wide range of rosacea treatments, including prescription medications, over-the-counter products, and specialized skincare regimens, all available with the ease of home delivery.

Asia Pacific rosacea treatment industry size will grow significantly through 2032 attributed to urbanization, heightened awareness of dermatological issues, and the adoption of advanced skincare solutions. As dermatological health gains prominence, the demand for effective rosacea treatments surges. Bolstered by an expanding healthcare infrastructure and innovative treatments tailored to diverse skin types, the regional market will witness an upward trajectory.

Table of Contents

135 Pages
Chapter 1 Methodology
1.1 Market segmentation
1.2 Market definitions
1.3 Research design
1.4 Market size estimates and calculations
1.4.1 Company share analysis
1.4.2 Prevalence based approach
1.4.3 Volume based approach
1.4.4 Bottom-up approach
1.5 Key trends for market estimates
1.6 Forecast model
1.7 Primary research & validation
1.7.1 Primary sources
1.7.2 Data mining sources
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis, 2021 - 2032
2.2 Type trends
2.3 Treatment type
2.4 Drug class trends
2.5 Distribution channel trends
2.6 Regional trends
Chapter 3 Rosacea Treatment Market Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of rosacea
3.2.1.2 Advancements in combination therapies and drugs
3.2.1.3 Rising awareness and diagnosis
3.2.1.4 Improving access to diagnosis and treatment
3.2.2 Industry pitfalls & challenges
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By treatment type
3.3.3 By drug class
3.3.4 By distribution channel
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Technology landscape
3.6 Pipeline analysis
3.7 Future market trends
3.8 Gap analysis
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.1.1 Galderma Laboratories, L.P.
4.1.2 LEO Pharma A/S
4.1.3 Dr. Reddy's Laboratories Ltd
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Rosacea Treatment Market, By Type
5.1 Erythematotelangiectatic rosacea (ETR)
5.2 Papulopustular rosacea
5.3 Ocular rosacea
5.4 Phymatous
Chapter 6 Rosacea Treatment Market, By Treatment Type
6.1 Oral
6.2 Topical
6.3 Other treatment types
Chapter 7 Rosacea Treatment Market, By Drug Class
7.1 Antibiotic
7.2 Alpha agonist
7.3 Retinoid
7.4 Corticosteroid
7.5 Immunosuppressant
7.6 Other drug classes
Chapter 8 Rosacea Treatment Market, By Distribution Channel
8.1 Hospital pharmacies
8.2 Retail pharmacies
8.3 Online pharmacies
Chapter 9 Rosacea Treatment Market, By Region
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and Africa
Chapter 10 Company Profile
10.1 Colorescience, Inc.
10.1.1 Global overview
10.1.2 Business overview
10.1.3 Financial data
10.1.4 Product landscape
10.1.5 SWOT analysis
10.2 Croda International Plc
10.2.1 Global overview
10.2.2 Business overview
10.2.3 Financial data
10.2.3.1 Annual sales revenue, 2023 - 2020 (USD Million)
10.2.4 Product landscape
10.2.5 SWOT analysis
10.3 Dr. Reddy's Laboratories Ltd
10.3.1 Global overview
10.3.2 Business overview
10.3.3 Financial data
10.3.3.1 Annual sales revenue, 2023 - 2020 (USD Million)
10.3.4 Product landscape
10.3.5 Strategic outlook
10.3.6 SWOT analysis
10.4 Galderma Laboratories, L.P.
10.4.1 Global overview
10.4.2 Business overview
10.4.3 Financial data
10.4.3.1 Annual sales revenue, 2023-2020 (USD Million)
10.4.4 Product landscape
10.4.5 Strategic outlook
10.4.6 SWOT analysis
10.5 Glenmark Pharmaceuticals Limited
10.5.1 Global overview
10.5.2 Business overview
10.5.3 Financial data
10.5.3.1 Annual sales revenue, 2023-2020 (USD Million)
10.5.4 Product landscape
10.5.5 SWOT analysis
10.6 Journey Medical Corporation
10.6.1 Global overview
10.6.2 Business overview
10.6.3 Financial data
10.6.3.1 Annual sales revenue, 2023-2020 (USD Million)
10.6.4 Product landscape
10.6.5 Strategic outlook
10.6.6 SWOT analysis
10.7 LEO Pharma A/S
10.7.1 Global overview
10.7.2 Business overview
10.7.3 Financial data
10.7.3.1 Annual sales revenue, 2023 - 2020 (USD Million)
10.7.4 Product landscape
10.7.5 SWOT analysis
10.8 Lupin
10.8.1 Global overview
10.8.2 Business overview
10.8.3 Financial data
10.8.3.1 Annual sales revenue, 2023-2020 (USD Million)
10.8.4 Product landscape
10.8.5 Strategic outlook
10.8.6 SWOT analysis
10.9 Maruho Co., Ltd.
10.9.1 Global overview
10.9.2 Business overview
10.9.3 Financial data
10.9.3.1 Annual sales revenue, 2023-2020 (USD Million)
10.9.4 Product landscape
10.9.5 SWOT analysis
10.10 Mayne Pharma Group Limited
10.10.1 Global overview
10.10.2 Business overview
10.10.3 Financial data
10.10.3.1 Annual sales revenue, 2023-2020 (USD Million)
10.10.4 Product landscape
10.10.5 Strategic outlook
10.10.6 SWOT analysis
10.11 Padagis LLC
10.11.1 Global overview
10.11.2 Business overview
10.11.3 Financial data
10.11.4 Product landscape
10.11.5 Strategic outlook
10.11.6 SWOT analysis
10.12 Perrigo Company plc
10.12.1 Global overview
10.12.2 Business overview
10.12.3 Financial data
10.12.3.1 Annual sales revenue, 2023-2020 (USD Million)
10.12.4 Product landscape
10.12.5 SWOT analysis
10.13 PruGen Pharmaceuticals
10.13.1 Global overview
10.13.2 Business overview
10.13.3 Financial data
10.13.4 Product landscape
10.13.5 SWOT analysis
10.14 Sol-Gel Technologies Ltd.
10.14.1 Global overview
10.14.2 Business overview
10.14.3 Financial data
10.14.3.1 Annual sales revenue, 2023-2020 (USD Million)
10.14.4 Product landscape
10.14.5 Strategic outlook
10.14.6 SWOT analysis
10.15 Teva Pharmaceutical Industries Limited
10.15.1 Global overview
10.15.2 Business overview
10.15.3 Financial data
10.15.3.1 Annual sales revenue, 2023-2020 (USD Million)
10.15.4 Product landscape
10.15.5 Strategic outlook
10.15.6 SWOT analysis
10.16 Zydus Lifesciences Limited
10.16.1 Global overview
10.16.2 Business overview
10.16.3 Financial data
10.16.3.1 Annual sales revenue, 2023-2020 (USD Million)
10.16.4 Product landscape
10.16.5 Strategic outlook
10.16.6 SWOT analysis

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us